SHAREHOLDERS EQUITY |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SHAREHOLDERS EQUITY | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SHAREHOLDERS' EQUITY |
7. SHAREHOLDERS’ EQUITY
Shares Outstanding
The table below details the change in Company shares outstanding by class during the three months ended March 31, 2024:
The Super Voting Shares carry 1,000 votes per share. The Subordinate Voting Shares carry 1 vote per share.
Warrants
A reconciliation of the beginning and ending balances of warrants outstanding is as follows:
For the three months ended March 31, 2024, on a weighted average basis, warrants outstanding have an exercise price of $1.52 and expire in February, 2025. Warrants convert into subordinate voting shares. |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|